In a study of 462 patients presenting with metastatic bone disease to the extremities or pelvis and undergoing orthopedic treatment, only preoperative hemoglobin was found to be an independent predictor of increased survival. Conversely, lung histotype, age, pathologic fracture, and previous combined therapy were all negative predictors of survival. It has also been observed that life expectancy tends to be longer for patients with a primary breast or prostate carcinoma than for those with lung carcinoma. Patients with renal cell or thyroid carcinoma have a variable life expectancy.
Learn more about prognostic factors here.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Maurie Markman. Fast Five Quiz: How Much Do You Know About Metastatic Bone Disease? - Medscape - May 20, 2019.